Thomas Bender CEO of The Cooper Companies Talks to the Wall Street Transcript
Thomas Bender CEO of The Cooper Companies Talks to the Wall Street Transcript
The entire 2,500 word interview is available free online at http://www.twst.com/ceos.htm
The Cooper Companies, Inc. is a rapidly growing specialty healthcare company. Its two business units serve attractive niche markets in the medical device market with high quality, proprietary products. CooperVision (CVI) markets a broad range of contact lenses throughout the world. CooperSurgical(CSI) markets diagnostic products, surgical instruments and accessories for the women's healthcare market.
In describing the Company's position in the contact lens market Mr. Bender states "We are in a great market, the contact lens space, and we've been by far and away the best performing company of any contact lens company over the last five or six years. Nobody has performed quite like we have in growth and gaining market share."
Regarding the company's future strategy in women's health care, Mr. Bender states "In the past three years, the objective has been to expand the product line that we are bringing to the gynecologists. We have invested in incontinence, not only in screening for incontinence but also in therapy that we believe the gynecologists can perform. We have invested in infertility, the largest, fastest growing segment in women's health care."
The Wall Street Transcript does not endorse the views of any interviewees nor does it make stock recommendations. For subscription information call 800-246-7673.
CONTACT:
The Cooper Companies, Inc.
Norris Battin, 949-597-4700
nbattin@coopercompanies.com
SOURCE: The Cooper Companies, Inc.